Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital

By Wick M. C.   Ernestam S.   Lindblad S.   Bratt J.   Klareskog L.   van Vollenhoven R. F.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 5, 2005-10 ,pp. : 353-358

Informa Healthcare

Access to resources Recommend Favorite

Delirium in Clinical Practice: Experiences from a SpecializedDelirium Ward

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 5, 1999-08 ,pp. : 389-392

Karger

Access to resources Recommend Favorite

Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry

By Cabriada J.  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 359-365

Springer Publishing Company

Access to resources Recommend Favorite

Potassium Abnormalities in Current Clinical Practice: Frequency, Causes, Severity and Management

By  

Medical Principles and Practice, Vol. 24, Iss. 3, 2015-03 ,pp. : 271-275

Karger

Access to resources Recommend Favorite

Successful retreatment with infliximab in patients with prior severe infusion reactions

By Uthman Imad   Touma Zahi   El-Sayyad Jinane   Zaitoun Fares  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 540-541

Springer Publishing Company

Access to resources Recommend Favorite